Possible impact of electronegative LDL on atherosclerosis in type 2 diabetes

Kouichi Tamura; Kotaro Haruhara; Kengo Azushima; Yasuo Tokita; Hiromichi Wakui

doi:10.1016/j.atherosclerosis.2017.08.018

Possible impact of electronegative LDL on atherosclerosis in type 2 diabetes

Atherosclerosis. 2017 Oct:265:253-255. doi: 10.1016/j.atherosclerosis.2017.08.018. Epub 2017 Aug 26.

Authors

Kouichi Tamura¹, Kotaro Haruhara², Kengo Azushima³, Yasuo Tokita⁴, Hiromichi Wakui²

Affiliations

¹ Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Electronic address: tamukou@med.yokohama-cu.ac.jp.
² Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
³ Cardiovascular & Metabolic Disorders Programme, Duke-NUS Medical School, Singapore.
⁴ Renal Division, Department of Medicine, Fujisawa Municipal Hospital, Japan.

PMID: 28851481
DOI: 10.1016/j.atherosclerosis.2017.08.018

No abstract available

Keywords: Clinical risk assessment and management; Cytokine; Lipid profile; Monocytes; Oxidative stress; Protein modification; Translational studies.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Atherosclerosis*
Diabetes Mellitus, Type 2*
Humans
Lipoproteins, LDL

Substances

Lipoproteins, LDL